ISSN: 2476-2490
Authors: Arellano Barcenas A*
The European Commission, in its surveillance program for rare cancers, has defined a rare neoplasm as one with an incidence of 6 per 100,000 people per year. Within this definition, dermal pleomorphic sarcoma is found. Being a tumor whose origin remains unknown and without knowing the cell that originates it, the diagnosis is one of exclusion. For the diagnosis, the support of an expert pathologist and the use of immunohistochemistry and genomic techniques are suggested. The clinical case of a patient with this pathology is presented, which, due to its low prevalence, is important for dissemination among health professionals for a correct diagnosis.
Keywords: Pleomorphic Sarcoma; Immunohistochemistry; Rare Tumors
